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Notations
	 ∈ 1,… , N 	individuals
	 ∈ 1, … , P 		SNVs
X= genotype matrix (N x P) for one gene
X ∈ 0,1,2 : genotype of individual i
for the SNV j
Yi ∈ 0,1 : phenotype of subject i
BOMP
A MAF threshold
defines RVs.
KBAC
VT
genotype matrix
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Burden Or Mutation Position test is an hybrid
likelihood approach that combines a burden test
with a test of the position distribution of variants.
C-alpha statistics tests the presence
of a mixture of risk, protective or
neutral variants.
Variable Threshold method is based on
the intuition that there exists an
(unknown) threshold T for which
variants with MAF ≤ T are substantially
more likely to be functional.
167 Controls
Calcific Aortic Valve 
Stenosis patients (CAVS)
167 Cases
Brugada syndrome 
patients (BrS)
Population sampling design
163 targeted genes  
Brugada syndrome: a rare heritable arrhythmia
syndrome associated with an increased risk of 
sudden cardiac death (12).
Targeted sequencing design
Genome-wide association studies (GWAS) aim to identify
genetic loci of susceptibility of complex diseases. These
studies require:
• sampling of individuals from 2 types of individuals:
cases and controls
• genotyping of individuals for a dense set of genetics
variants (Single Nucleotide Variants (SNVs)) across the
whole genome.
Exome sequencing studies: Exons of genes are sequenced
for cases and controls.
Minor Allele Frequency (MAF): frequency at which the
least common allele occurs in a given population.
Rare variant (RV): mutation present in less than 1-5% of the
population. (SNV with MAF 1-5%).
Controls
Disease-free 
Cases
Diseased
Potential disease-susceptibility allele
Background and Objectives
GWASs allow to identify common genetic variants
(CVs) associated with many common diseases. But
these variants do not fully explain the heritability (i.e.
proportion of phenotypic variance attributable to genetic variance).
Exome sequencing 
studies
CDCV hypothesis
(Common Disease Common 
Variant) 
CDRV hypothesis
(Common Disease Rare Variant) 
Material and Methods
Problems:
• Most popular statistical tests for GWAS based on
testing single SNP are powerless due to
rare + low effects
• Development of many statistical tests specifically
targeting RVs to detect association between a set of
variants (e.g. located on a gene) and a disease.
Our Objectives:
Which ? Comparative evaluation of the existing tests for the
identification of disease-associated RVs in order to identify
the most suitable ones in the context of associated RVs.
Why ? There exists a lot of tests but none is uniformly most
powerful. Adaptive tests are needed!
How ? With simulated data and real data.
Real 
sequencing
data
Simulated
data
Genotypes and phenotypes generated as in (11), 6 main scenarios, sub-divided
into several scenarios, 500 independent replicates, test significant level   5%,
500 permutations for permutation-based methods:
- sample size 500 cases and 500 controls;
- 8 causal RVs, p∈ 0,4,8,16,32 non causal RVs;
- #  0 independent or #  0.9 in Linkage Disequilibrium (LD).
Results
Conclusion and Perspectives
 Simulated data: simulations are time-consuming even with the use of parallel computing!
Perspectives: tests comparison for all scenarios and also for a population genetics model.
 Real sequencing data: detection of differences between tests in a practical set-up. It reveals difficulties linked to
preprocessing steps and also to the experimental design (choice of controls).
Perspectives: recommendations on the use of RVs tests and strategy to detect RVs on real data.
 The definition of a more powerful test depends on the unknown truth (of the association pattern):
improvements to existing tests like adaptive tests are needed!
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A: 8 deleterious causal RVs with common OR=2.
 Ideal situation for pooled association tests. Their
performance deteriorates when the number of non-
causal RVs increases.
 KBAC is the most powerful.
Scenario 1: Independent RVs: no LD between RVs.
Scenario 2: RVs in LD : all RVs (both causal and non-causal) correlated.
Scenario 3: No LD between causal RVs and non-causal RVs: causal RVs correlated, non-causal RVs
correlated.
Scenario 4: Independent RVs and LFVs (non-causal): independent RVs and 4 non-causal LFVs.
Scenario 5: Independent RVs and LFVs: independent RVs and 4 LFVs (3 non-causal and 1 causal).
Scenario 6: Independent RVs, LFVs and CVs: independent RVs, 4 non-causal LFVs and 2 non-causal CVs.
Evaluation:
 Type I error rate analysis (OR=1 in the logistic regression model generating phenotypes: null case);
 Empirical power analysis (OR≠1: non-null cases).
B: 8 causal RVs with no constant association strengths.
 Pooled association tests CAST, WSS and VT suffer
from loss of power.
 C-Alpha, SKAT, SKAT-O and KBAC perform similarly
and are most powerful.
Scenario 1: Satisfactory Type I error rates for all tests.
LMJ
1 2 … P
1 0 1 0
2 0 0 0
…
N 0 0 … 0
GWAS
Missing heritability
CAST
Cohort Allelic Sum Test compares the
proportion of cases that present at
least one RV with that of controls.
Weighted-Sum Statistic is analogous
to the Mann-Whitney-Wilcoxon
rank test, with weights on RVs.
aSUM
After preprocessing, 135 matrices (one per studied gene)  
1 to 280 variants in column and the 334 patients in line.
(*) poss.=possible, but not necessarily by default.
Summary of properties of the tests for RVs to be compared: 
Whether pooling over variants, using a MAF threshold to define RVs, 
sensitive to association directions (+/-),  whether possible use of  weights, 
requiring permutations for p-value calculations and references for more details.
Combined Multivariate and
Collapsing test modifies the CAST
to improve its performance when
both RVs and CVs are present.
Adaptive Sum test introduces data-
adaptive weights to differentiate between
beneficial, neutral or deleterious variants.
Kernel-based adaptive Clustering method
groups mutation patterns across the variants
and assigns each mutation pattern a kernel-
based weight adaptively determined by data.
Generalization of C-alpha test, Sequence Kernel Association Test uses a multiple regression
approach with introduction of kernel. The optimal test (SKAT-O) is a generalized family of SKAT
tests that incorporates a correlation structure of variants effects.
Pipeline of data creation and analysis
Variant category RV LFV (Low Frequency Variant) CV (Common Variant)
MAF [0,001; 0,01] ]0,01; 0,05] ]0,05; 0,1]
Cardiac arrhythmias
Per genePer variant
Filter 1
Fisher’s test 
(cases vs
controls)
Excluded if p-
value < 1%
Filter 2 
Excluded if absent from 
1000G/ESP data but 
detected in ≥ 5% in 
cases and/or controls
Filter 3 (RARE)
Excluded if 
frequency ≥ 1% 
in 1000G 
and/or ESP
Statistical tests 
for RVs
(*) Also named burden tests.
Test
Pool MAF threshold
Sensitive 
to +/-
weights Permut Refs
CAST yes fixed no no no 1
CMC yes fixed no no poss.(*) 2
WSS yes no no yes yes 3
aSUM yes no yes poss. yes 4
VT yes variable no no yes 5
KBAC no fixed no yes yes 6
C-Alpha no fixed yes poss. yes 7
SKAT no no yes poss. poss. 8
SKAT-O no no yes poss. poss. 9
BOMP hybrid no yes poss. yes 10
 The first dimension remains linked to
 all studied burden tests and
 some non-burden tests: SKAT-O, KBAC
and BOMP.
 The second dimension appears as the
dimension of two non-burden tests:
 C-Alpha and its generalization SKAT.
Correlation PCA on -log10(p-values) matrix 
135 genes x tests for RVs - MAF threshold defining RVs = 0,01
A
Power analysis 
B
